Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective (Q83940125)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 March 2010
edit
Language Label Description Also known as
English
Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
scientific article published on 29 March 2010

    Statements

    Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit